Navigation Links
New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
Date:2/11/2009

/i>" commented Dr. Stefan H. Hohnloser J.W., Goethe University's Division of Clinical Electrophysiology, Frankfurt, Germany, principal investigator of the ATHENA study.

Reported significant adverse events in the Multaq(R) arm vs. placebo arm included diarrhea (9.7% vs. 6.2%), nausea (5.3% vs. 3.1%), bradycardia (3.5% vs. 1.2%), QT-interval prolongation (1.7% vs. 0.6%); skin disorders (10.3% vs. 7.6%) consisting mainly of rash, and an increase in blood creatinine (4.7% vs. 1.3%)*. There was no difference in permanent study drug discontinuation between Multaq(R) and placebo (30.2% vs. 30.8%).

Dr. Stuart J. Connolly, Director of the division of cardiology at McMaster University, Ontario, Canada and co-principal investigator of the ATHENA trial said "The clinical benefits observed with dronedarone in ATHENA occurred without a significantly higher rate of thyroid or pulmonary disorders compared with placebo reported within the study period."

About the ATHENA Study

The landmark ATHENA study is the only double-blind, antiarrhythmic study in patients with AF that assesses morbidity-mortality. The study was conducted at more than 550 sites in 37 countries and enrolled a total of 4,628 patients.

The patients studied in ATHENA were either 75 years of age or older (with or without cardiovascular risk factors) or below 75 years of age with at least one additional cardiovascular risk factor (hypertension, diabetes, previous ischemic cerebrovascular event, left atrium size greater than 50 mm or left ventricular ejection fraction lower than 40 percent). Patients with recently decompensated heart failure or in New York Heart Association (NYHA) class IV were excluded. Patients were randomized to receive dronedarone 400 mg BID or placebo, with a mean follow-up of 21 months.

The ATHENA study objectives were designed to show a potential benefit of dronedarone
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
2. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
3. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
4. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
5. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
6. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
7. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
8. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
9. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
10. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
11. Diamyd(R) Study Published in Prestigious New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Array BioPharma ... results for the fourth quarter and full ... conference call to discuss those results on ... Executive Officer and Michael Carruthers , ... Call InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. Eastern ...
(Date:7/28/2014)... 28, 2014  A prospective study conducted by ... has validated the performance of VolparaDensity breast ... associated volumetrically assessed breast density measurements to breast ... & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated ... widespread breast cancer risk assessment," was authored by ...
(Date:7/28/2014)... -- Houston dentist , Dr. Behzad Nazari ... Invisalign. With access to this increasingly popular orthodontic ... without feeling self-conscious in the process. Invisalign offers ... of braces, but patients who choose Invisalign over ... support for their oral health and comfort during ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2
... a good night,s sleep to overall health have long been ... gender and weight management play in overall sleep patterns.  The ... Sleep and BMI , was presented during a poster session ... week. (Photo: http://photos.prnewswire.com/prnh/20111004/NE78562 ) ...
... YORK, Oct. 4, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0177915/US-Market-for-Neurological-Devices-2010.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment In 2009, ... valued at just over $2.2 billion, an ...
Cached Medicine Technology:Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 2Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 3U.S. Market for Neurological Devices 2010 2U.S. Market for Neurological Devices 2010 3U.S. Market for Neurological Devices 2010 4U.S. Market for Neurological Devices 2010 5U.S. Market for Neurological Devices 2010 6U.S. Market for Neurological Devices 2010 7U.S. Market for Neurological Devices 2010 8U.S. Market for Neurological Devices 2010 9U.S. Market for Neurological Devices 2010 10U.S. Market for Neurological Devices 2010 11U.S. Market for Neurological Devices 2010 12U.S. Market for Neurological Devices 2010 13U.S. Market for Neurological Devices 2010 14U.S. Market for Neurological Devices 2010 15U.S. Market for Neurological Devices 2010 16U.S. Market for Neurological Devices 2010 17
(Date:7/28/2014)... HealthDay Reporter MONDAY, ... appear to have a slightly increased risk of potentially ... Swedish researchers report. Doctors have previously suspected that ... raised risk of deep vein thrombosis and pulmonary embolism, ... veins, the researchers noted in background information. This ...
(Date:7/28/2014)... 28, 2014 The Oneida Indian Nation ... incredible field of accompanying PGA TOUR players will be ... analyst Notah Begay III for the seventh annual Notah ... Stone Resort Casino ’s Atunyote® Golf Club on Wednesday, ... Woods, Jason Dufner, Jimmy Walker, Jonas Blixt, Angel Cabrera ...
(Date:7/28/2014)... mobile devices are on the cusp of revolutionizing health ... providing everything from cardiac measurements to sonograms. , While ... and control costs, several health law experts say in ... (NEJM) report that more oversight is needed by the ... confidence and safety. Out of some 100,000 mHealth apps ...
(Date:7/28/2014)... New York (PRWEB) July 28, 2014 ... edition of “Organic Living” on March 12th, a campaign ... an organic lifestyle. In partnership with industry leader ... over 100 Certified Organic teas, the campaign provides readers ... recent years that continues to propel the industry forward ...
(Date:7/28/2014)... July 28, 2014 Irresistible infants have met their ... of Comfort. The online gifting company specializes in homemade chicken noodle ... The New Baby package starts with home-from-the-hospital essentials every new parent ... 6 rolls , 6 cookies , ... The soup is ready to heat and eat upon delivery, so ...
Breaking Medicine News(10 mins):Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
... oncologist and Craig Greven, Vitreoretinal surgeon, Wake Forest University ... with radiation therapy. Uveal malignant melanoma// is a rare ... people per year in the United States. It is ... seen in nonwhite races. The results of the study ...
... was first initiated in India to help overcome Vitamin ... in India, it now lags behind African and neighbouring ... report.,The report entitled "Controlling Vitamin and Mineral Deficiencies in ... the largest percentage as well as the largest absolute ...
... Alzheimer’s disease (AD), characterized by progressive memory loss, decline ... a major threat to ageing population.// ,A ... reviews the different strategies in drug discovery. Hong-Yu Zhang, ... of the present one-drug-one-target strategy in drug discovery is ...
... levels of low density lipoprotein (LDL) (also called bad ... are taking statins.// ,Those taking high doses of ... milligrams/deciliters to as low as 40 mg/dL. No one ... P. Cannon, a cardiologist at Brigham and Women's Hospital ...
... to a diverse range of insults, such as surgery, ... range of cell types of the immune system, creating ... inflammatory response, although essential for fighting infection, may damage ... mediators, cytokines and lipid mediators being the key mediators. ...
... Singh and Union Health Minister Anbumani Ramadoss are to convene ... problem of bird flu epidemic. //Awareness of bird flu and ... to the Western countries. The World Health Organization has sent ... if there are any possible flu attack. Dr. Anbumani said ...
Cached Medicine News:Health News:Radiation therapy effective against Eye cancer 2Health News:Vitamin A supplementation inadequate in India: Need for effective strategies 2Health News:The ideal composition of intravenous lipid emulsion 2
Triad Plus PVP-I Scrub Winged Sponges...
Prevail is a fast-acting, effective antimicrobial gel that makes preoperative preps easier. This unique gel formulation comes in a specifically designed, easy to use applicator for excellent flow con...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... Performance Panel consists of plasma specimens with ... for antibodies to the Hepatitis C Virus. ... manufacturers and diagnostic laboratories to evaluate their ... test systems are included for comparative analysis ...
Medicine Products: